Stock listing

NASDAQ:UTHR United Therapeutics Corporation Stock

Home listing (NASDAQ) of United Therapeutics Corporation

Follow United Therapeutics Corporation into a list and get an email when it puts out news.

Share price · NASDAQ:UTHR

$533.12 USD -8.39 (-1.5%)

Close on Oct 16, 2026

United Therapeutics Corporation logo
Ticker
NASDAQ:UTHR
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • United Therapeutics (NASDAQ:UTHR) Q2 2026 Earnings Call

    Wed, Aug 05, 2026 · 9:00 AM ET

    Watch Transcript

  • United Therapeutics (NASDAQ:UTHR) Q1 2026 Earnings Call

    Wed, May 06, 2026 · 9:00 AM ET

    Watch Transcript

  • United Therapeutics (NASDAQ:UTHR) Q4 2025 Earnings Call

    Wed, Feb 25, 2026 · 9:00 AM ET

    Watch Transcript

Latest news

United Therapeutics Presents New Data at the CHEST 2026 Annual Meeting

Oct 13, 2026

United Therapeutics Corporation Prevails in Patent Litigation Against Liquidia

Sep 30, 2026

United Therapeutics Corporation Announces Accelerated Share Repurchase Agreement for Remainder of $2.0 Billion Authorization

Sep 8, 2026

United Therapeutics Corporation Announces FDA Acceptance of Supplemental New Drug Application for Nebulized Tyvaso® to Treat Idiopathic Pulmonary Fibrosis

Sep 2, 2026

United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences

Sep 1, 2026

United Therapeutics Presents Data at The European Society of Cardiology Congress 2026 and The European Respiratory Society International Congress 2026

Aug 28, 2026

United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial Hypertension

Aug 24, 2026

United Therapeutics Corporation Announces Full Enrollment of the TETON-PPF Study of Inhaled Treprostinil for the Treatment of Progressive Pulmonary Fibrosis

Aug 17, 2026

United Therapeutics Corporation Reports Second Quarter 2026 Financial Results

Aug 5, 2026

FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease

Jul 31, 2026

All United Therapeutics Corporation news

Decks

United Therapeutics Corporation on 6ix

News releases
43 in the last 12 months · 220 in all · newest Oct 13, 2026 · oldest 2019
Calls
22 calls with a replay · 22 with a transcript · latest Aug 5, 2026
Decks
22 decks · latest Aug 5, 2026

Where United Therapeutics Corporation is listed

ListingExchangeCountryCurrency
NASDAQ:UTHR · Home listing · This pageNASDAQUnited StatesUSD
gettex:UTHgettexGermanyEUR
LS Exchange:923818LS ExchangeGermanyEUR
Lang & Schwarz:923818Lang & SchwarzGermanyEUR
BMV:UTHRBMVMexicoMXN
Tradegate:UTHTradegateGermanyEUR
B3:U2TH34B3BrazilBRL
Frankfurt:UTHFrankfurtGermanyEUR
Munich:UTHMunichGermanyEUR
BIVA:UTHRBIVAMexicoMXN
BOATS:UTHRBOATSUnited StatesUSD
BX Swiss:UTHBX SwissSwitzerlandCHF
Dusseldorf:UTHDusseldorfGermanyEUR
Stuttgart:UTHStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about United Therapeutics Corporation.